Brief: China Resources Pharmaceutical Says 9-Month Revenue For KPC Pharmaceuticals RMB5.61 Bln
Oct 30 (Reuters) - China Resources Pharmaceutical Group
Ltd 3320.HK :
* 9-MONTH REVENUE FOR KPC PHARMACEUTICALS RMB5.61 BILLION
VERSUS
RMB6.19 BILLION
* 9-MONTH REVENUE FOR KPC PHARMACEUTICALS NET PROFIT
RMB396.2
MILLION VERSUS RMB380.3 MILLION
Source text for Eikon: ID:nHKSbh0m1Z
Further company coverage: 3320.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Resources Pharmaceutical
See all newsBrief: China Resources Pharmaceutical Says KPC Pharmaceuticals Reports Nine Month Results
Brief: China Resources Pharmaceutical Group Declares Interim Dividend Of RMB0.087 Per Share
Brief: China Resources Pharmaceutical Says Tasly Pharmaceutical Posts HY Net Profit Attributable Of RMB 892.7 MLN
Brief: China Resources Pharmaceutical Group Says HY Revenue RMB 1.93 Billion For CR Jiangzhong
Brief: China Resources Pharmaceutical Group Posts HY Revenue RMB 1.64 Billion, Down 50.97% For KPC Pharmaceuticals